| Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial MD Hill, M Goyal, BK Menon, RG Nogueira, RA McTaggart, AM Demchuk, ... The Lancet 395 (10227), 878-887, 2020 | 535 | 2020 |
| Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial V Meininger, A Genge, LH van den Berg, W Robberecht, A Ludolph, ... The Lancet Neurology 16 (3), 208-216, 2017 | 82 | 2017 |
| The CpxRA two-component system is essential for Citrobacter rodentium virulence JL Thomassin, N Giannakopoulou, L Zhu, J Gross, K Salmon, JM Leclerc, ... Infection and Immunity 83 (5), 1919-1928, 2015 | 35 | 2015 |
| The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis K Salmon, MC Kiernan, SH Kim, PM Andersen, A Chio, LH Van den Berg, ... Brain 145 (4), 1207-1210, 2022 | 34 | 2022 |
| Assessment of discrepancies between follow-up infarct volume and 90-day outcomes among patients with ischemic stroke who received endovascular therapy A Ganesh, JM Ospel, BK Menon, AM Demchuk, RA McTaggart, ... JAMA network open 4 (11), e2132376-e2132376, 2021 | 26 | 2021 |
| Genetic testing for amyotrophic lateral sclerosis in Canada–an assessment of current practices K Salmon, N Anoja, A Breiner, M Chum, A Dionne, N Dupré, A Fiander, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23 (3-4), 305-312, 2022 | 17 | 2022 |
| Systematic analysis of two-component systems in Citrobacter rodentium reveals positive and negative roles in virulence JL Thomassin, JM Leclerc, N Giannakopoulou, L Zhu, K Salmon, A Portt, ... Infection and immunity 85 (2), 10.1128/iai. 00654-16, 2017 | 14 | 2017 |
| ALSUntangled no. 26: lunasin ALSUntangled Group Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15 (7-8), 622-626, 2014 | 12 | 2014 |
| ALSUntangled No. 30: Methylcobalamin ALSUntangled Group Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16 (7-8), 536-539, 2015 | 10 | 2015 |
| ALSUntangled# 64: butyrates Y Sun, R Bedlack, C Armon, M Beauchamp, T Bertorini, R Bowser, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23 (7-8), 638-643, 2022 | 9 | 2022 |
| Predictive genetic testing for Motor neuron disease: time for a guideline? A McNeill, MM Amador, H Bekker, A Clarke, A Crook, C Cummings, ... European Journal of Human Genetics 30 (6), 635-636, 2022 | 8 | 2022 |
| The NEALS primary lateral sclerosis registry S Paganoni, F De Marchi, J Chan, SK Thrower, NP Staff, N Datta, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21 (sup1), 74-81, 2020 | 8 | 2020 |
| Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial M Benatar, T Hansen, D Rom, MA Geist, T Blaettler, W Camu, ... The Lancet Neurology 23 (7), 687-699, 2024 | 5 | 2024 |
| Mediation of age and Thrombectomy outcome by neuroimaging markers of frailty in patients with stroke F Benali, N Singh, J Fladt, T Jaroenngarmsamer, F Bala, JM Ospel, ... JAMA Network Open 7 (1), e2349628-e2349628, 2024 | 5 | 2024 |
| ALSUntangled# 63: ketogenic diets R Bedlack, PE Barkhaus, B Barnes, M Beauchamp, T Bertorini, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24 (1-2), 159-163, 2023 | 5 | 2023 |
| ALSUntangled 53: Carnitine supplements ALSUntangled Group Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21 (5-6), 477-483, 2020 | 4 | 2020 |
| ALSUntangled# 67: rituximab X Li, C Armon, P Barkhaus, B Barnes, M Benatar, T Bertorini, M Bromberg, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 24 (5-6), 544-547, 2023 | 3 | 2023 |
| The value of testing for ATXN2 intermediate repeat expansions in routine clinical practice for amyotrophic lateral sclerosis K Salmon, JP Ross, V Bertone, M Gobbo, N Anoja, J Karamchandani, ... European Journal of Human Genetics 30 (11), 1205-1207, 2022 | 2 | 2022 |
| ALSUntangled# 61: melatonin ALSUntangled Group Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23 (1-2), 157-160, 2022 | 2 | 2022 |
| ALSUntangled 59: Tamoxifen: The Alsuntangled Group R Bedlack, S Kihuwa-Mani, PE Barkhaus, M Bereman, JB Caress, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22 (7-8), 595-598, 2021 | 2 | 2021 |
